Hoogenboom Tim Ch, Thursz Mark, Aboagye Eric O, Sharma Rohini
Department of Experimental Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 0HS, UK.
Department of Hepatology, Imperial College NHS Trust, 10th Floor, Norfolk Place, St Mary's Hospital, London, UK.
Hepat Oncol. 2016 Apr;3(2):137-153. doi: 10.2217/hep-2015-0005. Epub 2016 Mar 29.
Imaging plays a key role in the clinical management of hepatocellular carcinoma (HCC), but conventional imaging techniques have limited sensitivity in visualizing small tumors and assessing response to locoregional treatments and sorafenib. Functional imaging techniques allow visualization of organ and tumor physiology. Assessment of functional characteristics of tissue, such as metabolism, proliferation and stiffness, may overcome some of the limitations of structural imaging. In particular, novel molecular imaging agents offer a potential tool for early diagnosis of HCC, and radiomics may aid in response assessment and generate prognostic models. Further prospective research is warranted to evaluate emerging techniques and their cost-effectiveness in the context of HCC in order to improve detection and response assessment.
影像学在肝细胞癌(HCC)的临床管理中起着关键作用,但传统成像技术在可视化小肿瘤以及评估局部区域治疗和索拉非尼的反应方面敏感性有限。功能成像技术能够实现对器官和肿瘤生理学的可视化。评估组织的功能特征,如代谢、增殖和硬度,可能会克服结构成像的一些局限性。特别是,新型分子成像剂为HCC的早期诊断提供了一种潜在工具,而放射组学可能有助于反应评估并生成预后模型。有必要进行进一步的前瞻性研究,以评估新兴技术及其在HCC背景下的成本效益,从而改善检测和反应评估。